---
title: "Harmony Biosciences｜8-K：2025 財年 Q3 營收 2.39 億美元超過預期"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/262433821.md"
published_at: "2025-10-23T12:16:12.000Z"
---

# Harmony Biosciences｜8-K：2025 財年 Q3 營收 2.39 億美元超過預期

營收：截至 2025 財年 Q3，公佈值為 2.39 億美元，市場一致預期值為 2.2 億美元，超過預期。

### 財務指標概述

#### 收入

-   WAKIX®（匹託利桑）特許經營在 2025 年第三季度實現淨收入約 2.39 億美元，同比增長 29%。

#### 運營指標

-   該季度的患者平均數量增加了約 500 人，達到 8,100 名患者，推動了 WAKIX 在嗜睡症領域的潛在重磅藥物地位。

#### 前景/指導

-   公司將 2025 年的收入指導從之前的 8.2 億至 8.6 億美元上調至 8.45 億至 8.65 億美元。
-   這些前瞻性聲明基於管理層當前的意見、預期、信念、計劃、目標、假設或對未來事件或結果的預測。
-   實際結果、活動水平、績效、成就和事件可能與這些前瞻性聲明中所述、預期或暗示的內容有重大差異。

### Related Stocks

- [HRMY.US - Harmony Biosciences](https://longbridge.com/zh-HK/quote/HRMY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 14:57 ETQvinci and Harmonyze Announce Strategic Partnership to Elevate Franchise Performance Coaching | Qvinci Software and Harmonyze have announced a strategic partnership aimed at enhancing franchise performance coaching.  | [Link](https://longbridge.com/zh-HK/news/275651785.md) |
| Sandip Kapadia Sells 3,746 Shares of Harmony Biosciences (NASDAQ:HRMY) Stock | CFO Sandip Kapadia of Harmony Biosciences sold 3,746 shares at $37.15 each, totaling $139,163.90, reducing his ownership | [Link](https://longbridge.com/zh-HK/news/274076411.md) |
| Assessing Harmony Biosciences (HRMY) Valuation As Growth, Financial Strength And Technical Signals Attract Investors | Harmony Biosciences (HRMY) is attracting investor interest due to its revenue and earnings growth, solid financial posit | [Link](https://longbridge.com/zh-HK/news/273826298.md) |
| Harmony Biosciences CFO Sandip Kapadia Reports Disposal of Common Shares | Sandip Kapadia, CFO of Harmony Biosciences Holdings Inc., reported the disposal of common shares of the company. The ful | [Link](https://longbridge.com/zh-HK/news/274069011.md) |
| Harmony Biosciences CFO Sells Over 20K Shares | Harmony Biosciences CFO Sandip Kapadia sold 20,961 shares of common stock on January 15, 2026, at a weighted average pri | [Link](https://longbridge.com/zh-HK/news/273157191.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。